Skip to content

Clinical trials

Phase 3 Glomerulonephritis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis Phase: Phase 3 Country / region: Taiwan Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20201
20211
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Recruiting3
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Human Genome Sciences Inc., a GSK Company1
National Taiwan University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis8
Glomerulonephritis, IGA6
Kidney Diseases5
Renal Insufficiency, Chronic5
Urologic Diseases4
Autoimmune Diseases2
Nephritis2
Female Urogenital Diseases1
Female Urogenital Diseases and Pregnancy Complications1
Immune System Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.